Literature DB >> 7247321

Prophylactic methenamine hippurate or nitrofurantoin in patients with an indwelling urinary catheter.

P Nyrén, L Runeberg, A I Kostiala, O V Renkonen, R Roine.   

Abstract

One hundred and twenty three elderly patients without urinary tract infection who required an indwelling urinary catheter because of cerebrovascular disease were divided into three groups. One was given methenamine hippurate (MH), one nitrofurantoin (NF), while a control group received no prophylactic urinary tract disinfectant. Catheter complications, symptomatic urinary tract infections and the clinical course were recorded. At regular intervals bacteria were cultured from the urine, tests were made for antibody-coated bacteria (ACB) and routine laboratory investigations were performed. NF significantly delayed the appearance of ACB; however, it did not prevent their appearance if a catheter was used for more than two months, by which time ACB were present in most patients irrespective of treatment. MH had less effect on the bacteriological findings, although it significantly decreased the need for antibiotic courses given for treatment of symptomatic urinary tract infections. In both MH- and NF-groups there were fewer patients with mechanical catheter complications. Forty seven patients died, generally due to cerebrovascular disease, and 22 autopsies were performed. Gross inflammatory changes in the urinary tract were commonly found at autopsy in all groups if a catheter had been used for more than two weeks. A positive test for ACB considerably increased the probability of inflammatory changes in the kidneys, but because of the frequency of such changes after prolonged use of an indwelling catheter, the test does not seem to offer much advantage as a guideline for therapy. Prophylactic urinary tract disinfectants may not be warranted in all patients with an indwelling catheter. If, however, recurrent clinical complications such as clogging of the catheter or symptomatic infection occur, continuous use of a urinary tract disinfectant is indicated. MH is preferred because it has fewer side effects than NF.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7247321

Source DB:  PubMed          Journal:  Ann Clin Res        ISSN: 0003-4762


  5 in total

1.  Activities of a nitrofurazone-containing urinary catheter and a silver hydrogel catheter against multidrug-resistant bacteria characteristic of catheter-associated urinary tract infection.

Authors:  J R Johnson; P Delavari; M Azar
Journal:  Antimicrob Agents Chemother       Date:  1999-12       Impact factor: 5.191

2.  A comparison of outcomes of transurethral versus suprapubic catheterization after Burch cystourethropexy.

Authors:  Terry S Dunn; Johanna Figge; Doug Wolf
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2004-07-28

3.  An evaluation of the management of asymptomatic catheter-associated bacteriuria and candiduria at The Ottawa Hospital.

Authors:  Dawn M Dalen; Rosemary K Zvonar; Peter G Jessamine
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-05       Impact factor: 2.471

4.  Complicated urinary tract infection in adults.

Authors:  L E Nicolle
Journal:  Can J Infect Dis Med Microbiol       Date:  2005-11       Impact factor: 2.471

Review 5.  Methenamine hippurate for preventing urinary tract infections.

Authors:  Bon San B Lee; Tushar Bhuta; Judy M Simpson; Jonathan C Craig
Journal:  Cochrane Database Syst Rev       Date:  2012-10-17
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.